Eli Hoffmann
Eli Hoffmann
Send Message
Eli Hoffmann
Stop FollowingEli Hoffmann
View as an RSS Feed
COMMENTS STATS
532 Comments
565 Likes

My Last Article And My Last Best Idea [View article]
Our intention with SA Pro was to incentivize high-quality ("Alpha-Rich") opportunity-driven research by offering a small embargo (24 hours) to users willing to pay for it, and turning much of that additive revenue (or, at this early stage, all of it and then some) back to contributors. Unlike most articles, "Pro" articles receive guaranteed minimum payments that are significantly higher than the average "ad-revenue share" non Pro articles receive.
So far, we've seen a significant uptick in high-quality long/short ideas, which are the meat-and-potatoes of Pro. You can see the full stream of articles here (except for any articles published in the past 24 hours): http://bit.ly/11N8sXB
Contributors told us that most alpha opportunities, not surprisingly, are in lesser-followed stocks. Because of this, the ad-share model works poorly for alpha-rich opportunities, because on average they receive far fewer page-views. Hence, the guaranteed minimum payment.
Are there some contributors that would have shared anyway? Yes. Are they happier with the current model (minimum flat payment) than they were with the page-view model? I imagine so. On balance, are all SA users getting a much richer stream of "Alpha-Rich" opportunity-driven long and short ideas - albeit with a small embargo? I believe so.
My Last Article And My Last Best Idea [View article]
I'm not sure why you felt the need to take a dig at us. At any rate, at the risk of sounding semantic, I want to clarify our model: We do not pay for research. We are not a paid research platform, and our best contributors' research (and Thomas is clear among the best) is pretty darn close to priceless. What we do is share ad revenues with contributors so that they profit together with us. Contributors such as Thomas aren't in it for the little money we can offer, but we feel it's only fair that they take part in our success.
Two old Jonathan Lebed/momentum trader favorites - BroadVision (BVSN +14.9%) and Synacor (SYNC +16.1%) - are shooting higher. This morning, BroadVision announced giant Japanese carrier NTT will use the company's software to power a cloud-based enterprise task management service, and Synacor announced (in what doesn't seem like big news) it would demo its Cloud ID solution (allows TV Everywhere logins via Facebook/Twitter/Google+) at this week's Google I/O conference. [View news story]
Aereo seems to be expanding faster than broadcasting networks can fire off their legal missives. The company announced it will be available in Atlanta on June 17 to be followed shortly by another 21 cities. Backed by InterActiveCorp (IACI +0.7%), the re-transmission upstart continues to be a thorn in the side of the media industry, particularly CBS (CBS +1.1%) with its reliance on fees from pay-TV operators. [View news story]
My Last Article And My Last Best Idea [View article]
It's been great having you as a Pro contributor, and you'll be missed by this reader/editor and I expect others as well.
But I think you've made a real name for yourself here. Were I looking for a fund manager right now, you'd be on my short-short list!
Eli
Key Items To Consider For Velti's May 13, 2013 Earnings Report [View article]
http://bit.ly/179jK9u
Intuitive Surgical (ISRG) issues "urgent medical device notification" regarding "micro-cracks" (which the company warns may not be visible to the naked eye) in mono polar curved scissors that could result in leaks, creating a "pathway for electrosurgical energy" to reach tissue, causing "thermal injury" (i.e. burns). Shares -2.63% premarket. (Herb Greenberg) [View news story]
Xinyuan Real Estate (XIN): Q1 EPS of $0.37 vs. $0.31 last year. Revenue of $169.4M. (PR) [View news story]
The Problems With Ackman's Thesis On Procter & Gamble [View article]
What Is Imperial Holdings Worth? Free 1 Month Cruise To The Bermuda Triangle For 636 Of Imperial's Insureds [View article]
Why I Believe Molycorp Will Trend Lower [View article]
http://seekingalpha.co...
Can Uroplasty Drive Adoption Of Its Better Mousetrap? [View article]
http://bit.ly/12iFzPM
Xinyuan Real Estate (XIN): Q1 EPS of $0.37 vs. $0.31 last year. Revenue of $169.4M. (PR) [View news story]
IPO Preview: ING U.S. [View article]
The Gulf Of Mexico Is A Winner For This Independent [View article]